- George Sakoulas, MD
New findings confirm that systemic antibiotic therapy after drainage of small abscesses offers added benefit over no treatment.
- Neil M. Ampel, MD
In a retrospective study of 48 patients, estimated survival was 50% at 1 year.
- Neil H. Winawer, MD, SFHM
A retrospective study shows that telemetry watchers reduced nursing burden by intercepting many nonactionable alarms.
- Thomas L. Schwenk, MD
Electronic reminders, financial incentives, and social support had no effect on clinical outcomes or adherence.
- Abigail Zuger, MD
A novel schema for presenting surgical risks to frail elders might help foster better care.
- Atif Zaman, MD, MPH
Pretransplantation anti–hepatitis C virus therapy was cost effective only in patients with a MELD score of 21 or lower.
- Grace C. Huang, MD
Isolation for patients with respiratory illnesses and resistant staph infections is associated with longer stays and higher hospital costs.
- Paul S. Mueller, MD, MPH, FACP
In a meta-analysis, neither gliptins nor glucagon-like peptide-1–receptor agonists conferred excess risk for all-cause death.
- David J. Bjorkman, MD, MSPH (HSA), SM (Epid.)
Urgent endoscopy is associated with lower mortality, but not with a lower rate of rebleeding.
- Bruce Soloway, MD
In a patient older than 75 who takes antiplatelet drugs for secondary prevention, a proton-pump inhibitor should be strongly considered.
- Allan S. Brett, MD
Another observational study suggests an association, but a causal relation has not been proven.
- Kirsten E. Fleischmann, MD, MPH
Almost 40% of eligible AF patients don't receive oral anticoagulants, despite introduction of DOACs.
- Allan S. Brett, MD
The drug conferred small, statistically significant cardiovascular and renal benefits.
- Mark S. Link, MD
Implantable cardioverter-defibrillators reduce mortality — in specific patient populations.
- Daniel M. Lindberg, MD
In the continued quest for reduced response times for patients with cardiac arrest, one city turned to the police.
- Daniel J. Pallin, MD, MPH
In a simulated randomized trial, emergency department patients with chest pain who underwent provocative testing had more interventions but not fewer myocardial infarctions than those who did not undergo testing.
- David Green, MD, PhD
A systematic literature review finds DOACs safe and effective for HIT.
- Daniel Kaul, MD
Cytomegalovirus can be effectively suppressed in such patients, and valganciclovir may be a better choice than high dose valacyclovir.
- Seemant Chaturvedi, MD
A randomized trial shows no difference in outcomes after lying flat or having the head raised for 24 hours after a stroke.
- Howard C. Herrmann, MD
A high rate of adverse events prompts the question of whether earlier intervention would improve outcomes.
HIV and ID Observations